Leukemic cells isolated from a newly diagnosed APL patient were treated for 96 hours with either 1 μmol/L RA or 100 μmol/L zVAD or with the combination of both agents as indicated. (A) Immunoblot analysis performed using the anti-RARα RPα(F) antibody; (B) percentage of differentiated cells determined by NBT reduction assay.